Evidence map›Paper›PMID 27790998›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias.

Jae-Won Shin, David J Mooney

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Hippo Pathway in Breast Cancer: The Extracellular Matrix and Hypoxia.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Modelling the disease: HMaterials today. Bio · 2023
    Article
  18. LAIR-1 agonism as a therapy for acute myeloid leukemia.The Journal of clinical investigation · 2023
    Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jae-Won ShinSchool of Engineering and Applied Sciences, Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA 02138; Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612; Department of Bioengineering, University of Illinois College of Medicine, Chicago, IL 60612.
David J MooneySchool of Engineering and Applied Sciences, Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA 02138; mooneyd@seas.harvard.edu.
Harvard University · US

Funding

Building the Hematopoietic Stem Cell NicheR01EB014703 · NIBIB · HARVARD UNIVERSITY · PI MOONEY, DAVID J, SCADDEN, DAVID T · 2011 to 2014
$3.1M
Mechanically controlled release of hematopoietic factors from mesenchymal stromal cells for blood regenerationR00HL125884 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHIN, JAE-WON · 2016 to 2018
$747k
Mechanically controlled release of hematopoietic factors from mesenchymal stromal cells for blood regenerationK99HL125884 · NHLBI · HARVARD UNIVERSITY · PI SHIN, JAE-WON · 2015 to 2016
$176k
NHLBI NIH HHS K99 HL125884NHLBI NIH HHS R00 HL125884NIBIB NIH HHS R01 EB014703
6 · The paper itself

Abstract

Extracellular matrix stiffness influences biological functions of some tumors. However, it remains unclear how cancer subtypes with different oncogenic mutations respond to matrix stiffness. In addition, the relevance of matrix stiffness to in vivo tumor growth kinetics and drug efficacy remains elusive. Here, we designed 3D hydrogels with physical parameters relevant to hematopoietic tissues and adapted them to a quantitative high-throughput screening format to facilitate mechanistic investigations into the role of matrix stiffness on myeloid leukemias. Matrix stiffness regulates proliferation of some acute myeloid leukemia types, including MLL-AF9

Indexed as

Gene Expression Regulation, LeukemicAnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationExtracellular MatrixFusion Proteins, bcr-ablHardnessHigh-Throughput Screening AssaysHumansHydrogelsLeukemia, Myeloid, AcuteMice, Inbred NODMice, SCIDMyeloid-Lymphoid Leukemia ProteinOligopeptidesAntineoplastic Agentsarginyl-glycyl-aspartic acidFusion Proteins, bcr-ablHydrogelsMLL-AF9 fusion protein, humanMyeloid-Lymphoid Leukemia ProteinOligopeptidesOncogene Proteins, FusionProto-Oncogene Proteins c-aktraf Kinasesbiomaterialscancerdrug screeningmatrix stiffnesssystems pharmacology

Identifiers

PMID27790998
PMCPMC5086998
OpenAlexW2530700316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.